FR | EN
Simulate my exposure →
In the pharmaceutical industry, clinical trials have zero tolerance for travel disruptions. ZEPHYR Intelligence protects the coordination of your 400+ active field operations.
disruptions impacting clinical trial operations
active clinical trial sites protected simultaneously
advance notice to reschedule without protocol impact
A blocked consultant loses a day. A blocked clinical investigator can invalidate an entire cohort, costing months of research and millions in sunk cost.
Patient visits, sample collections, and assessments have strict time windows. A 24-hour delay can remove a patient from the protocol entirely.
Your investigators travel across 400+ sites in Europe. A cascading disruption (ATC strike, weather event) can hit 50 sites simultaneously.
The average cost of a delay in a Phase III trial is estimated at €600,000/day. An investigator grounded for 48h can cost millions in trial delays.
ZEPHYR maps all your investigator travel in real time, scores each route by disruption risk, and automatically triggers alternatives — before the problem materializes.
Connected to your TMC. Automatic identification of trips linked to protocol deadlines within 72 hours.
Every flight receives a risk score updated every 15 minutes: weather, delay history, GDS capacity, social signals.
As soon as the risk threshold is crossed, ZEPHYR proposes (or executes) an alternative rebooking — 12 to 48 hours before the disruption is confirmed.
Every decision is logged with a timestamp and rationale for your regulatory file. Complete audit trail included.
"ZEPHYR enabled us to reduce by 60% the disruptions impacting our field operations. Across 400+ active trial sites in Europe, this is a major operational transformation. ROI is visible from the first quarter."
VP Travel & Fleet Operations — CAC 40 Pharmaceutical Group
We analyze your current investigator routes and show you the alerts ZEPHYR would have triggered last month.
Request the Pharma demo →